Evidence map›Paper›PMID 34138505›Full record

ArticleBJOG : an international journal of obstetrics and gynaecology2021

Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.

N Boydell, J J Reynolds-Wright, S T Cameron, J Harden

Open access · hybridAbstract read
In one paragraph

Article in BJOG : an international journal of obstetrics and gynaecology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Provider Mistrust and Telemedicine Abortion Care Preferences Among Patients in Ohio, West Virginia, and Kentucky.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

N BoydellUsher Institute, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-2260-8020
J J Reynolds-WrightNHS Lothian, Edinburgh, UK.ORCID 0000-0001-6597-1666
S T CameronNHS Lothian, Edinburgh, UK.ORCID 0000-0002-1168-2276
J HardenUsher Institute, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-6011-6254
NHS Lothian · GBUniversity of Edinburgh · GB

Funding

Medical Research Council MR/N022556/1NHS Lothian Sexual Health and Blood Borne Virus Programme Fund R46498-R46499The Health Foundation's grant to the University of Cambridge for The Healthcare Improvement Studies Institute
6 · The paper itself

Abstract

objectiveTo explore the experiences of women in Scotland who accessed medical abortion at home up to 12 weeks' gestation, delivered via a telemedicine abortion service implemented in response to the coronavirus (COVID-19) pandemic, to identify areas for improvement and inform service provision.

designQualitative interview study.

settingAbortion service in one National Health Service health board in Scotland. POPULATION OR SAMPLE: Twenty women who accessed telemedicine abortion services and self-administered mifepristone and misoprostol at home up to 12 weeks' gestation.

methodsThematic analysis of semi-structured qualitative interviews, informed by the Framework analytic approach.

main outcome measuresWomen's experiences of accessing telemedicine for medical abortion at home, specifically: acceptability of the telephone consultation and remote support; views on no pre-abortion ultrasound scan; and self-administration of abortion medications at home.

resultsNovel study findings were three-fold: (1) participants valued the option of accessing abortion care via telemedicine and emphasised the benefits of providing a choice of telephone and in-person consultation to suit those with different life circumstances; (2) the quality of abortion care was enhanced by the telemedicine service in relation to access, comfort and flexibility, and ongoing telephone support; (3) participants described being comfortable with, and in some cases a preference for, not having an ultrasound scan.

conclusionsThis research demonstrates support for the continuation of telemedicine abortion services beyond the temporary arrangements in place during COVID-19, and lends weight to the argument that offering the option of telemedicine abortion care can enable women to access this essential health service. TWEETABLE ABSTRACT: #Telemedicine provision of medical #abortion at home up to 12 weeks' gestation is acceptable and highly valued by #women #Research #SRHR @nbw80 @doctorjjrw @jeniharden @cameronsharon @mrc_crh @edinuniusher.

Indexed as

Patient SatisfactionAbortifacient Agents, NonsteroidalAbortion, InducedAdultCOVID-19FemaleHealth Services AccessibilityHumansMifepristoneMisoprostolPregnancyQualitative ResearchSARS-CoV-2ScotlandSelf AdministrationState MedicineAbortifacient Agents, NonsteroidalMifepristoneMisoprostolHealth services researchqualitative researchteleconsultation/telehealthtermination of pregnancytermination of pregnancy: medicalwomen’s experiences

Identifiers

PMID34138505
PMCPMC8441904
OpenAlexW3166540663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.